Upside – $MRLN +40% (Q3 revenue rose 80% year over year, while new U.S. special-operations and autonomous-CASEVAC awards strengthened the defense pipeline) – $MOD +38% (Samsung reportedly in talks to acquire the data-center cooling supplier, with a potential deal possible within weeks) – $SLSN +32% (Q3 revenue grew 38% and the company swung to record …
Read in context ›Broadcom Stock (AVGO)
Track Broadcom stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
Read the latest TheStreet Pro articles mentioning Broadcom, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
508 articlesDaily Diary Mentions
27 mentionsModine Manufacturing Up; Virgin Galactic Down: Upside, Downside Movers in A.M. Chips Stocks Up, Inovio & Alcon Down: Upside Downside Movers in the A.M. Upside – $FOSL +23% (Q3 beat, gross margin surged and the FY sales and profit outlook was raised) – $SATL +21% (record Q3 revenue, positive adjusted EBITDA and a post-quarter deal to sell three in-orbit satellites for about $37M) – $RSKD +20% (Q3 revenue growth accelerated to 41% and revenue and adjusted EBITDA guidance was …
Read in context ›Market Observation As it relates to heavily weighted large-cap technology, the election will likely delay the construction of data centers. This means an entire portion of large cap (the “component” companies like Broadcom ($AVGO), Nvidia ($NVDA), Micron ($MU), Advanced Micro Devices ($AMD), Intel ($INTC), Sandisk ($SNDK), etc.) all face an increasingly uncertain sales and profit outlook. (Peripheral …
Read in context ›SoFI Up, HSBC Down: Upside, Downside Movers in the Morning Upside – $MFIC +23% (ARCC agrees to acquire it for $10.88 per share in cash and stock, valuing the transaction at about $2.6B) – $INIO +14% (record Q3 results and FY26 revenue and EBITDA outlooks were raised) – $CLS +12% (Q3 beat, FY26 outlook raised and initial 2027 guidance called for 90% revenue growth on …
Read in context ›Select Upside, Downside Movers in the Morning Upside – $IRON +52% (Phase 3 APOLLO trial met all primary and secondary endpoints in erythropoietic protoporphyria) – $AAME +41% (long-delayed 2025 annual report was filed, showing a return to annual profitability) – $XLAB +24% (extends rally after securing an $8.2M AI-server order) – $TCRT +20% (extends volatile rally tied to a proposed acquisition and …
Read in context ›



